By NewsDesk  @bactiman63 A dual therapy treatment regimen of expanded-spectrum cephalosporins (ESCs) plus azithromycin (AZM) is the recommended standard of care for gonorrhea. A strain of the Neisseria...

Genome sequencing has shed light on the re-emergence of the bacterium that causes yaws, a neglected tropical disease of the skin, bones and joints. The re-emergence followed a mass drug administration...

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...

Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs’ potentially...

The Food and Drug Administration (FDA) issued a warning Friday concerning the long-term use of azithromycin (Zithromax, Zmax) for prophylaxis of bronchiolitis obliterans syndrome to patients who undergo...

In a follow-up to recommendations published in April 2017, the Centers for Disease Control and Prevention (CDC) issued updated recommendations on management and reporting of Shigella infections that...

A recent CDC MMWR report shows that providers treated 81% of patients diagnosed with gonorrhea using CDC’s recommended dual therapy. While encouraging, nearly 1 in 5 patients were treated with a different...

In a follow-up on the first global report of HLAziR N. gonorrhoeae which is also resistant to ceftriaxone in a United Kingdom man, Public Health England (PHE) reports investigating a UK case of Neisseria...

The Lancet has published a new study led by Oriol Mitjà, first author and researcher at the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation,...